Enlivex Hit With Nasdaq Delisting Notice, No 180-Day Cure After Reverse Split
ENLV is trading near its 52-week low of $2.562 (93% below the low).
Summary
Enlivex received a Nasdaq delisting notice after its bid price stayed below $1.00 for 30 business days, and it gets no 180-day cure period because of a recent reverse split. The company will appeal to a Nasdaq hearings panel, which stays any suspension while the appeal is pending.
Key Events · Legal and Risk Events · ENLV
-
Nasdaq Delisting Notice Received
Nasdaq's Listing Qualifications Department issued a delisting notification dated October 26, 2026, stating the closing bid price failed the $1.00 minimum under Rule 5550(a)(2) over the 30 consecutive business days prior to October 22, 2026.
-
No 180-Day Cure Period
Because Enlivex effected a reverse split within the preceding 12 months, it is not entitled to the standard 180-day period to regain compliance with the minimum bid price requirement.
-
Appeal to Hearings Panel
The company plans to request an oral hearing before the Nasdaq Hearings Panel under Rule 5815; the request stays any suspension or delisting action while the appeal is pending, and shares continue trading on the Nasdaq Capital Market in the interim.
-
1-for-16 Reverse Split Effective
Enlivex effected a 1-for-16 reverse split of its ordinary shares, effective October 27, 2026, in an effort to regain compliance and support the appeal.
Analysis · ENLV · Crypto Assets
Nasdaq has told Enlivex its shares failed the $1.00 minimum bid for 30 straight business days, and because the company already did a reverse split in the past year it gets no 180-day grace period — the usual safety net is gone. The only path left is an appeal to the Nasdaq Hearings Panel, which pauses any suspension while it is pending but does not guarantee the listing survives. For a company this small, a delisting would push trading to the OTC market, thinning liquidity and cutting off access to the institutional and index money that Nasdaq listing supports. Effective today, the 1-for-16 reverse split is the company's attempt to lift the bid price and strengthen the appeal, but it does not by itself resolve the deficiency.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 45.6% of the 241 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENLV was trading at $0.17 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $2.56 to $434.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.